Expression of ζ molecules is decreased in NK cells from HIV-infected patients

FEMS Immunology and Medical Microbiology

Volumn 26, Issue 3-4, 1999, Pages 249-257

  Geertsma, M F ^a   Stevenhagen, Annelies ^a   Van Dam, Ellen M ^a   Nibbering, Peter H ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Molecule; AIDS; Antibody dependent cellular cytotoxicity; CD16; Cytolysis; Natural killer cell

Indexed keywords

CD16 ANTIGEN; MONOCLONAL ANTIBODY;

ADULT; AGED; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ARTICLE; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOLYSIS; DISEASE COURSE; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS LOAD; VIRUS PATHOGENESIS;

ADULT; AGED; ANTIBODIES, MONOCLONAL; ANTIBODY-DEPENDENT CELL CYTOTOXICITY; FEMALE; FLOW CYTOMETRY; HIV INFECTIONS; HIV-1; HUMANS; KILLER CELLS, NATURAL; MALE; MEMBRANE PROTEINS; MIDDLE AGED; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, IGG; VIRAL LOAD;

EID: 0033485902     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-8244(99)00151-0     Document Type: Article

References (51)

1. Clerici M., Stocks N.I., Zajac R.A., Boswell R.N., Lucey D.R., Via C.S., Shearer G.M. Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive patients. J. Clin. Invest. 84:1989;1892-1899.
2. + T cell function in the course of human immunodeficiency virus infection: gradual decline of both naive and memory alloreactive cells. J. Clin. Invest. 94:1994;1947-1952.
3. Shearer G.M., Bernstein D.C., Tung K.S.K., Via C.S., Redfield R., Salahuddin S.Z., Gallo R.C. A model for the selective loss of major histocompatibility complex self-restricted T cell immune responses during the development of acquired immune deficiency syndrome (AIDS). J. Immunol. 137:1990;2514-2521.
4. Tyler D.S., Stanley S.D., Nastala C.A., Austin A.A., Bartlett J.A., Stine K.C., Lyerly K.C., Bolognesi D.P., Weinhold K.J. Alterations in antibody-dependent cellular cytotoxicity during the course of HIV-1 infection. Humoral and cellular defects. J. Immunol. 144:1990;3375-3384.
5. Ullum H., Gøtzsche P.C., Victor J., Dickmeiss E., Skinhøj P., Pedersen B.K. Defective natural immunity: an early manifestation of human immunodeficiency virus infection. J. Exp. Med. 182:1995;789-799.
6. Robinson W.E., Mitchell W.M., Chambers W.H., Schuffman S.S., Montefiori D.C., Oeltmann T.N. Natural killer cell infection and inactivation in vitro by the human immunodeficiency virus. Hum. Pathol. 19:1988;535-540.
7. Goicoa M.A., Sen L., Iannitelli P.S., Diez R.A., Estevez M.E. Natural killer suppressor factors in sera from HIV-infected subjects. Scand. J. Immunol. 41:1995;523-528.
8. Cauda R., Tumbarello M., Ortona L., Kanda P., Kennedy R.C., Chanh T.C. Inhibition of normal human natural killer cell activity by human immunodeficiency virus synthetic transmembrane peptides. Cell. Immunol. 115:1988;57-65.
9. Bonavida B., Katz J., Gottlieb M. Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-reelated complex. I. Defective trigger on NK cells for NKCF production by target cells, and partial restoration by IL2. J. Immunol. 137:1986;1157-1163.
10. Sirianni C., Soddus S., Malorni W., Arancia G., Aiuti F. Mechanisms of defective natural killer cell activity in patients with AIDS is associated with defective distribution of tubulin. J. Immunol. 140:1988;2565-2568.
11. Trinchieri G. Biology of natural killer cells. Adv. Immunol. 47:1990;187-376.
12. Anderson P., Caliguri M., Ritz J., Schlossman S.F. CD3-negative natural killer cells express ζ TCR as part of a novel molecular complex. Nature. 341:1989;159-162.
13. Lanier L.L., Yu G., Philips J.H. Co-association of CD3ζ with a receptor (CD16) for IgG Fc on human natural killer cells. Nature. 342:1989;803-805.
14. Letourneur O., Kennedy I.C.S., Brini A.T., Ortaldo J.R., O'Shea J.J., Kinet J.-P. Characterization of the family of dimers associated with Fc receptors (FcεR1 and FcγRIII). J. Immunol. 147:1991;2652-2656.
15. Reth M. Antigen receptor tail clue. Nature. 338:1989;383-384.
16. Samelson L.E., Klausner R.D. Tyrosine kinases and tyrosine-based activation motifs. Current research on activation via the T cell antigen receptor. J. Biol. Chem. 267:1992;24913-24916.
17. O'Shea J.J., Weissman A.M., Kennedy I.A.S., Ortaldo J.R. Engagement of the natural killer cell IgG Fc receptor results in tyrosine phosphorylation of the ζ chain. Proc. Natl. Acad. Sci. USA. 88:1991;350-354.
18. Vivier E., Morin P., O'Brien C., Druker B., Schlossman S.F., Anderson P. Tyrosine phoshorylation of the FcγRIII(CD16):ζ complex in human natural killer cells. J. Immunol. 146:1991;206-210.
19. lck activation. J. Exp. Med. 176:1992;1751-1755.
20. 2) activity in human natural killer cells. J. Immunol. 158:1997;3148-3154.
21. Trotta R., Kanakaraj P., Perussia B. FcγR-dependent mitogen-activated protein tyrosine kinase activation in leukocytes: a common signal transduction event necessary for expression of TNF-α and early activation genes. J. Exp. Med. 184:1996;1027-1035.
22. Bonnema B.J.D., Karnitz L., Schoon R.A., Abraham R.T., Leibson P.L. Fc receptor stimulation of phosphatidylinositol 3-kinas in natural killer cells is associated with protein tyrosine kinase C-independent granule release and cell-mediated cytotoxicity. J. Exp. Med. 180:1994;1427-1435.
23. Cerboni C., Gismondi A., Palmieri G., Piccoli M., Frati L., Santoni A. CD16-mediated activation of phosphatidylinositol-3 kinase (PI-3K) in human NK cells involves tyrosine phosphorylation of Cbl and its association with Grb2, Shc, pp36 and p85 PI-3K subunit. Eur. J. Immunol. 28:1998;1005-1015.
24. Weiss A., Littman D.R. Signal transduction by lymphocyte antigen receptors. Cell. 76:1994;263-274.
25. Finke J.H., Zea A.H., Stanley J., Longo D.L., Mizoguchi H., Tubbs R.R., Witrout R.H., O'Shea J.J., Kudoh S., Klein E., Bukowski R.M., Ochoa A.C. Loss of T-cell receptor ζ chain in T-cells infiltrating human renal cell carcinoma. Cancer Res. 53:1993;5613-5616.
26. Maurice M.M., Lankester A.C., Bezemer A.C., Geertsma M.F., Tak P.P., Breedveld F., Van Lier R.A.W., Verweij C. Defective TCR-mediated signalling in synovial T cells in rheumatoid arthritis. J. Immunol. 159:1998;2973-2978.
27. Nakagomi H., Petersson M., Magnusson I., Juhlin C., Matsuda M., Mellstedt H., Taupin J.-L., Vivier E., Anderson P., Keissling R. Decreased expresson of the signal-transducing ζ chains in tumor-inflitrating T cells and NK cells of patients with colorectal carcinoma. Cancer Res. 53:1993;5610-5616.
28. Matsuda M., Petersson M., Lenkei R., Taupin J.-L., Magnusson I., Mellstedt H., Anderson P., Kiessling R. Alterations in the signal-transducing molecules of T cells and NK cells in colorectal tumor-infiltrating, gut mucosal and peripheral lymphocytes: correlation with the stage of the disease. Int. J. Cancer. 61:1995;765-772.
29. Matsuda M., Ulfgren A.K., Lenkei R., Petersson M., Ochoa A.C., Lindblad S., Andersson P., Klareskog L., Kiessling R. Decreased expression of signal-transducing CD3 zeta chains in T cells from the joints and peripheral blood of arthritis patients. Scand. J. Immunol. 47:1998;254-262.
30. Anderson P., Blue M.L., O'Brien C., Schlossman S.F. Monoclonal antibodies reactive with the T cell receptor ζ chain: production and characterization using a new method. J. Immunol. 143:1989;1899-1904.
31. Moretta A., Ciccone E., Pantaleo G., Tambussi G., Bottino C., Melioli G., Mingari M.C., Moretta L. Surface molecules involved in the activation and regulation of T or natural killer lymphocytes in humans. Immunol. Rev. 111:1989;145-171.
32. Allen J.B., Wong H.L., Guyre P.M., Simon G.L., Wahl S.M. Association of circulating receptor FcγRIII-positive monocytes in AIDS patients with elevated levels of transforming growth factor-β J. Clin. Invest. 87:1991;1773-1779.
33. Ra C., Jouvin M.-H.E., Blank U., Kinet J.-P. A macrophage Fcγ receptor and the mast cell receptor for IgE share an identical subunit. Nature. 341:1989;752-754.
34. Masuda M., Verhoeven A.J., Roos D. Tyrosine phosphorylation of a γ chain homodimer associates with FcγRIII (CD16) in cultured monocytes. J. Immunol. 151:1993;6382-6388.
35. Kurosaki T., Gander I., Ravetch R.V. A subunit common to an IgG Fc receptor and the T cell receptor mediates assembly through different interactions. Proc. Natl. Acad. Sci. USA. 88:1991;3837-3841.
36. Geertsma M.F., Van Wengen-Stevenhagen A., Van Dam E.M., Risberg K., Kroon F.P., Groeneveld P.H.P., Nibbering P.H. Decreased expression of molecules by T lymphocytes is correlated with disease progression in HIV-infected patients. J. Infect. Dis. 180:1999;649-658.
37. Štefanová I., Saville M.W., Peters C., Cleghorn F.R., Schwartz D., Venzon D.J., Weinhold K.J., Jack N., Bartholomew C., Blattner W.A., Yarchoan R., Bolen J.B., Horak I.D. HIV-infection-induced posttranslational modification of T cell signaling molecules associated with disease progression. J. Clin. Infect. 98:1996;1290-1297.
38. Trimble L.A., Lieberman J. Circulating CD4 T lymphocytes in human immunodeficiency virus-infected individuals have imapired function and downmodulate CD3, the signaling chain of the T-cell receptor complex. Blood. 91:1998;585-594.
39. Anderson P., Caligiuri M., O'Brien C., Manley T., Ritz J., Schlossman S.F. Fcγ receptor type III (CD16) is included in the ζ NK receptor complex expressed by human natural killer cells. Proc. Natl. Acad. Sci. USA. 87:1990;2274-2278.
40. Kono K., Salazar-Onfray F., Petersson M., Hansson J., Masucci G., Wasserman K., Nakazawa T., Anderson P., Kiessling R. Hydrogen peroxide secreted by tumor-derived macrophages down-modulates signal transducing zeta molecules and inhibits tumor-specific T cell- and natural killer cell-mediated cytotoxicity. Eur. J. Immunol. 26:1996;1308-1313.
41. Otsuji M., Kimura Y., Aoe T., Okamoto Y., Saito T. Oxidative stress by tumor-derived macrophages suppresses the expression of CD3 of T-cell receptor complex and antigen-specific T-cell responses. Proc. Natl. Acad. Sci. USA. 93:1996;13119-13124.
42. Staal F.J.T., Ela S.W., Roederer M., Anderson M.T., Herzenberg L.A., Herzenberg L.A. Glutathione-deficiency and human immunodeficiency virus infection. Lancet. 339:1992;909-912.
43. Seaman W.E., Gindhart T.D., Blackman M.A., Dalal B., Talal N., Werb Z. Suppression of natural killing in vitro by monocytes and polymorphonuclear leukocytes. Requirement for reactive metabolites of oxygen. J. Clin. Invest. 69:1984;876-888.
44. Sirianni M.C., Mezzaroma I., Aiuti F., Moretta A. Analysis of the cytolytic activity mediated by natural killer cells from acquired immunodeficiency patients in response to haemagglutinin or anti-CD16 antibody. Eur. J. Immunol. 24:1994;1874-1878.
45. Brenner B.G., Dascal A., Margolese R.G., Wainberg M.A. Natural killer cell function in patients with acquired immunodeficiency syndrome and related diseases. J. Leuk. Biol. 46:1989;75-83.
46. Sivori S., Vitale M., Morelli L., Sanseverrino L., Augugliaro R., Bottino C., Moretta A., Moretta L. p46, a novel natural killer cell-specific surface molecule that mediates cell activation. J. Exp. Med. 186:1997;1129-1136.
47. Vitale M., Bottino C., Sivori S., Sanseverino L., Castriconi R., Marcenaro E., Augugliaro R., Moretta L., Moretta A. Nkp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis. J. Exp. Med. 187:1998;2065-2072.
48. Pessino A., Sivori S., Bottino C., Malaspina A., Morelli L., Moretta L., Biassoni R., Moretta A. Molecular cloning of Nkp46: a novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity. J. Exp. Med. 5:1998;953-960.
49. Chehimi J., Starr S.E., Frank I., Rengaraju M., Jackson S.J., Llanes C., Kobayashi M., Perussia B., Young D., Nickbarg E., Wolf S.F., Trinchier G. Natural killer (NK) cell stimulatory factor increases the cytotoxic activity of NK cells from both healthy donors and human immunodeficiency virus-infected patients. J. Exp. Med. 175:1992;789-796.
50. Vivier E., Morin P.M., O'Brien C., Schlossman S.F., Anderson P. CD2 is functionally linked to the zeta-natural killer receptor complex. Eur. J. Immunol. 21:1991;1077-1080.
51. + cells. J. Exp. Med. 12:1997;1957-1963.